This suggests the hypothesis that these four genes of low mutation rate play Stage I-specific roles, whereas classic cancer genes MAP3K1, PTEN, TP53, GATA3 and PIK3CA are important in the entire malignant progression of IDBC. Here, MAP3K1 is linked to cancer.